Plasma Cells, also known as effector B cells or antibody-producing cells, are a specialized type of immune cell derived from activated B lymphocytes. These cells play a pivotal role in the adaptive immune response by producing large quantities of antibodies, also called immunoglobulins, to recognize and neutralize specific pathogens such as bacteria, viruses, and toxins. Plasma cells are generated during the immune response when B cells encounter antigens, triggering their activation and differentiation. The differentiated plasma cells have a unique morphology, featuring an expanded endoplasmic reticulum to accommodate the increased synthesis of antibodies. The primary function of plasma cells is the secretion of antibodies tailored to bind with high specificity to the antigens that initiated their activation. Antibodies play various roles in immunity, such as neutralizing pathogens, facilitating their removal by other immune cells, and marking them for destruction. Plasma cells are short-lived, typically surviving for a few days to weeks. However, a subset of long-lived plasma cells, known as memory B cells, can persist for an extended period, providing long-term immunity upon re-exposure to the same pathogen. Immunohistochemical staining techniques, targeting specific proteins like CD138, help identify plasma cells in tissues and confirm their presence during immune responses. Elevated levels of plasma cells in certain tissues may indicate immune-related disorders, such as autoimmune diseases or plasma cell dyscrasias like multiple myeloma. Research on plasma cells is critical for understanding the dynamics of the immune response, vaccine development, and the pathogenesis of various immune-mediated diseases. Manipulating plasma cell activity holds potential for therapeutic interventions to enhance immunity or modulate inappropriate immune responses. In summary, plasma cells are key effectors of the adaptive immune response, producing antibodies to target and neutralize specific pathogens. Their short-lived nature, coupled with the presence of memory B cells, contributes to the immune system's ability to mount rapid and robust responses upon encountering familiar antigens.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States